I was allocated $13,500 this time round for the September 2.8% SSB. So my last 3 months' allocations are:
- 2.71% - $18,000
- 3% - $9,000
- 2.8% - $13,500
Tuesday 30 August 2022
Thursday 11 August 2022
GSK / Haleon : Zantec Litigation
Both GSK and HLN are falling due to worries about litigation over the Zantec drug.
Technically, HLN has nothing to do with it after demerger but yahoo news has reported that:
Haleon said it has certain indemnification obligations to GSK and Pfizer, “which may include liabilities related to OTC Zantac,” in a prospectus ahead of listing its shares in London last month. That’s while Credit Suisse analysts flagged Haleon’s involvement in Zantac litigation was limited.
Anyway, I bought some more Haleon today. This could be possible falling knife territory or it may be that the market is over-reacting to Haleon's possible exposure to the Zantec Litigation.
Wednesday 10 August 2022
Aviva and Strategy for August
Aviva shares jumped today by as much as 12% on better than expected results, an increased dividend, and a share buy-back plan.
As I have posted before, I only buy Aviva when it is below £4, so I was really lucky that my target price was reached in both July and August as that allowed me to accumulate more shares.
Aviva is now one of my top 10 holdings in my portfolio. There are only 2 individual stocks in my top 10, the other being OCBC. The remainder are 7 ETFs and 1 unit trust.
Apart from Aviva, I have also been accumulating Santander as it dropped below $2.50 again this month as I also think the price is right and this is the time to accumulate more. It will be entering my portfolio in the 'medium' category at the next update.
With the GSK/Haleon split, I am faced with having to decide which is more attractive. Another consideration is position size and since my Haleon position is smaller, I'm thinking of building it up. My entry price will be below £3 and coincidentally, Haleon is -6% today, so I added some.
Subscribe to:
Posts (Atom)